from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2902c/rnhB

LFCtreatmentdescriptionclass of inhibitor

-0.778

Amikacinug/mL Amikacintranslation

-1.562

Cap5-10ug/mL Capreomycintranslation

-2.114

Rox10-50 ug/mL Roxithromycintranslation

-0.301

SM2-5 ug/mL Streptomycintranslation

-0.937

Tet5-10 ug/mL Tetracyclinetranslation

0.522

Rif0.2-5ug/mL Rifampicintranscription

0.417

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.052

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.032

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.153

CPZ10-50 ug/mL Chlorpromazinerespiration

0.648

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.664

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.119

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.117

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.868

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.695

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.103

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.355

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.221

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.068

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.654

KCN5-20 ug/mL Potassium cyaniderespiration

0.086

NaN30.2-2 mM Sodium aziderespiration

0.070

Nigericin50 uM Nigericinrespiration

-0.025

TRC10-150 ug/mL Triclosanrespiration

0.336

TRZ10-25 ug/mL Thioridazinerespiration

-1.378

Valinomycin0.5-10 uM Valinomycinrespiration

-0.933

ZnSO42 mM ZnSO4respiration

1.058

menadione6-10 ug/mL Menadionerespiration

0.639

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.667

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.353

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.967

NRP_1Non-replicating persistence stage 1dosRassociated

-0.135

Amp0.2mg/mL AmpicillincellWall

-0.431

Cephalexin20-100 ug/mL CephalexincellWall

-0.275

Cerulenin0.32-5 ug/mL CerulenincellWall

0.019

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.062

EMB10-20 ug/mL EthambutolcellWall

-0.693

Eta12-40 ug/mL EthionamidecellWall

-0.856

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.361

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.688

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.838

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.011

BZA0.12 mg/mL BenzamidearomaticAmides

0.057

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.287

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.392

H2O24 mM hydrogen peroxideDNAdamaging

-0.347

Levo10 ug/mL LevofloxacinDNAdamaging

0.538

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.282

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.346

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.751

UVUV-irradiationDNAdamaging

0.975

ARP41-4 ug/mL Antitubercular compound ARP4?

0.412

Antimycin12.5-50 ug/mL Antimycin A?

0.258

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.314

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.444

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.653

PA8240.2-2 ug/mL PA-824?

0.790

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.889

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.359

Verapamil50 uM Verapamil?

0.989

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.390

methoxatin10-20 ug/mL Methoxatin?